These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22465021)

  • 1. Novel endocrine aspects of prostate cancer.
    Visakorpi T
    Mol Cell Endocrinol; 2012 Sep; 360(1-2):1-2. PubMed ID: 22465021
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostatic cancer and its androgen-dependency].
    Shimazaki J; Isaka S; Akimoto S; Sumiya H; Ichikawa T; Akakura K; Furuya Y
    Gan No Rinsho; 1989 May; Spec No():268-76. PubMed ID: 2513430
    [No Abstract]   [Full Text] [Related]  

  • 3. CK2 signaling in androgen-dependent and -independent prostate cancer.
    Wang G; Ahmad KA; Unger G; Slaton JW; Ahmed K
    J Cell Biochem; 2006 Oct; 99(2):382-91. PubMed ID: 16598768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen regulation of micro-RNAs in prostate cancer.
    Waltering KK; Porkka KP; Jalava SE; Urbanucci A; Kohonen PJ; Latonen LM; Kallioniemi OP; Jenster G; Visakorpi T
    Prostate; 2011 May; 71(6):604-14. PubMed ID: 20945501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.
    Zhang Z; Zhao Y; Batres Y; Lin MF; Ying SY
    Biochem Biophys Res Commun; 1997 May; 234(2):362-5. PubMed ID: 9177276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of apoptosis in prostatic androgen-independent cell lines.
    Salido M; López A; Aparicio J; Larran J; Vilches J
    Int J Dev Biol; 1996; Suppl 1():191S-192S. PubMed ID: 9087756
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgen action during prostate carcinogenesis.
    Wang D; Tindall DJ
    Methods Mol Biol; 2011; 776():25-44. PubMed ID: 21796518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
    Agoulnik IU; Weigel NL
    J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key targets of hormone treatment of prostate cancer. Part I: the androgen receptor and steroidogenic pathways.
    Pitts WR
    BJU Int; 2009 Nov; 104(9):1304. PubMed ID: 19824968
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modern approaches to treating locally-advanced and disseminated prostate cancer].
    Veliev EI
    Ter Arkh; 2002; 74(10):67-70. PubMed ID: 12469638
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer stem cells: are they androgen-responsive?
    Oldridge EE; Pellacani D; Collins AT; Maitland NJ
    Mol Cell Endocrinol; 2012 Sep; 360(1-2):14-24. PubMed ID: 21802490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of loss of androgen dependency in androgen-dependent tumor].
    Sato N; Suzuki H; Shimazaki J
    Hum Cell; 1993 Sep; 6(3):170-5. PubMed ID: 8297812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling.
    Mink SR; Hodge A; Agus DB; Jain A; Gross ME
    Prostate; 2010 Aug; 70(11):1201-10. PubMed ID: 20564426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular regulation of androgen action in prostate cancer.
    Dehm SM; Tindall DJ
    J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of steroid hormones in prostate cancer.
    Wilding G
    Cancer Surv; 1992; 14():113-30. PubMed ID: 1423327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.
    Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL
    Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between HER-2/neu over-expression and androgen independent prostate cancer].
    Bai Q; Chen F; Qi J; Chen JH; Wang YX
    Zhonghua Nan Ke Xue; 2007 May; 13(5):414-6. PubMed ID: 17569256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
    Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC
    Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine stimulation by gonadotrophin-releasing hormone-like factors of human hormone-responsive prostate cancer cells in culture.
    Qayum A; Scaletsky R; Waxman J
    Prog Clin Biol Res; 1990; 357():121-8. PubMed ID: 2170991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.